CAMBRIDGE, Mass., May 9 (UPI) --
The U.S. Defense Department says it has awarded funding for the Naval Medical Research Center to continue researching a combat casualty blood substitute.
The approximately $3.4 million in allocated funds is part of the Defense Department's multifunctional blood substitute for field resuscitation of polytrauma combat casualties with brain injury and concomitant hemorrhagic shock program. Officials say the Naval Medical Research Center will partner with Massachusetts-based Biopure Corp. for the development of Hemopure (HBOC-201) as a multifunction blood substitute.
Pre-clinical work on HBOC-201 will be conducted by the Naval Medical Research Center. Pending approval, Biopure will then conduct clinical trials with trauma patients. The HBOC-201 project is part of the U.S. Congress directed medical research, post traumatic stress disorder/traumatic brain injury research program.
"Biopure continues to support the Naval Medical Research Center's efforts toward lifting the clinical hold on the Naval Medical Research Center's new drug application investigation to conduct the pending, proposed clinical trial in trauma patients," the release said.© 2008 United Press International. All Rights Reserved.
This material may not be reproduced, redistributed, or manipulated in any form.